Patent · US Active

HIV protease inhibiting compounds

US7834043B2 · kind B2 · utility

1Cited by
9References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2004
Grant dateNov 16, 2010
Priority date—
Expiry dateDec 13, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/0207
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of the formulais disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.